Rockwell Medical shares are trading higher after HC Wainwright raised the price target for stock to $11 from $9, with a Buy rating.
Portfolio Pulse from Benzinga Newsdesk
Rockwell Medical's stock price target has been raised to $11 from $9 by HC Wainwright, who maintains a Buy rating on the stock.
July 17, 2023 | 5:13 pm
News sentiment analysis
Sort by:
Descending
POSITIVE IMPACT
Rockwell Medical's stock price target has been increased by HC Wainwright, which could lead to a positive impact on the stock's short-term price.
The increase in Rockwell Medical's stock price target by HC Wainwright indicates a positive outlook for the company's stock. This could lead to increased investor confidence and a potential rise in the stock's short-term price.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100